Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • mergers & acquisitions

    - PMLiVE

    Indegene acquires BioPharm to advance AI-driven life sciences marketing

    The acquisition strengthens Indegene’s AI-enabled commercialisation and AdTech capabilities

    - PMLiVE

    Indegene announces acquisition of Trilogy Writing & Consulting

    The deal is aimed at increasing Indegene’s clinical and regulatory writing expertise for global market authorisation applications

    - PMLiVE

    Novo Nordisk awakens its ‘Sleeping Beauty’

    Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott

    - PMLiVE

    Indegene Pharma Marketer 2020 Report predicts significant shift in channel spends

    Content personalisation to continue to yield disproportionate returns

    Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications

    by Marc Valdiviezo

    - PMLiVE

    Takeda rebels take aim at Shire acquisition

    Shareholder group concerned about $30bn debt burden

    - PMLiVE

    The bulk of pharma digital spend fails to alter industry’s greenhorn status

    Indegene’s Digital Maturity study reveals huge gaps in KPIs

    - PMLiVE

    OPEN Health acquires Choice Healthcare Solutions

    Will rebrand the agency under its Succinct agency offering

    Deal Watch March 2016

    AstraZeneca, Roche, Sanofi and Valeant are featured in this month’s roundup of pharma deals

    Sanofi reception

    Sanofi hints at sweetened Medivation deal – or hostile bid

    CEO Oliver Brandicourt claims “overwhelming support” for deal from shareholders

    - PMLiVE

    IMS Health to merge with Quintiles

    Will create pharma services firm worth almost $18bn

    Sanofi reception

    Medivation unimpressed with Sanofi’s offer

    CEO says the offer “substantially undervalues” the oncology specialist

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links